WST
West Pharmaceutical Services Exceeds Expectations with Strong Q2 2026 Earnings
West Pharmaceutical Services recently released its second-quarter financial results for 2026, exceeding expectations on both the top and bottom line. The company reported revenues of $872 million, a 13% organic increase, while adjusted earnings per share (EPS) came in at $2.37, up 29% from the prior year. According to